WARRANTS (Tables)

9 Months Ended

Sep. 30, 2024

The following table summarizes warrant activity through September 30, 2024:

SCHEDULE OF WARRANTS ACTIVITY

	Warrants Issued		Weighted-Average Exercise Price

Warrants outstanding – December 31, 2022		150,000	$	1.10
Granted		-		-
Canceled		-		-
Exercised		-		-
Warrants outstanding – December 31, 2023		150,000		1.10

Granted		1,650,000		3.0
Canceled		-		-
Exercised		-		-
Warrants outstanding – September 30, 2024		1,800,000	$	2.84

SCHEDULE OF WARRANTS OUTSTANDING

Additional information regarding the warrants outstanding as of September 30, 2024 is as follows:

SCHEDULE OF WARRANTS OUTSTANDING

Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life		Number Exercisable
$	1.10		150,000		3.4 Years		150,000
$	3.00		1,650,000		9.1 Years		766,667
			1,800,000				916,667

SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS

The fair value of such warrants was estimated on the date of grant to be $1.97 per share using the Black-Scholes option-pricing model with the following assumption weighted-averages in 2024:

Risk-free interest rates		3.14	%
Expected life in years		5.0
Expected volatility		80	%
Expected dividend yield		0	%
Fair value common stock	$	3.00

RetinalGenix Technologies Inc. 10-Q